{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T01:39:09Z","timestamp":1789609149639,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.jneuroim.2008.05.026","type":"journal-article","created":{"date-parts":[[2008,7,22]],"date-time":"2008-07-22T05:04:09Z","timestamp":1216703049000},"page":"104-110","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients"],"prefix":"10.1016","volume":"201-202","author":[{"given":"Fulvio","family":"Baggi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ubiali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Nava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Nessi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Andreetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rigamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Mantegazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Antozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2008.05.026_bib1","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2249.2003.02144.x","article-title":"Cytokine-based immunointervention in the treatment of autoimmune diseases","volume":"132","author":"Adorini","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.71.1.1","article-title":"IL-17: prototype member of an emerging cytokine family","volume":"71","author":"Aggarwal","year":"2002","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00315690","article-title":"A short plasma exchange protocol is effective in severe Myasthenia Gravis","volume":"238","author":"Antozzi","year":"1991","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.4049\/jimmunol.169.2.1077","article-title":"Resistance to experimental autoimmune Myasthenia Gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production","volume":"169","author":"Deng","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib5","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1111\/j.1468-1331.2005.01079.x","article-title":"Inhibition of IL-6 overproduction by steroid treatment before trans-sternal thymectomy for Myasthenia Gravis: does it help stabilize perioperative condition?","volume":"12","author":"Endo","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib6","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.4049\/jimmunol.174.11.6571","article-title":"The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance","volume":"174","author":"Fry","year":"2005","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0955-3886(90)90028-H","article-title":"Therapeutic protein A immunoadsorption. A review","volume":"11","author":"Gjorstrup","year":"1990","journal-title":"Transfus. Sci."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib8","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1096\/fj.01-0072com","article-title":"Suppression of experimental Myasthenia Gravis, a B cell-mediated autoimmune disease, by blockade of IL-18","volume":"15","author":"Im","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib9","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1212\/WNL.59.2.287","article-title":"Increased serum levels of the interferon-gamma-inducing cytokine interleukin-18 in Myasthenia Gravis","volume":"59","author":"Jander","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.05.026_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.55.1.16","article-title":"Myasthenia Gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America","volume":"55","author":"Jaretzki","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2008.05.026_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(93)90278-7","article-title":"Experimental allergic encephalomyelitis: neutralizing antibody to TGF beta 1 enhances the clinical severity of the disease","volume":"47","author":"Johns","year":"1993","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1196\/annals.1254.019","article-title":"Pathogenic autoantibodies in the Lambert-Eaton Myasthenic Syndrome","volume":"998","author":"Lang","year":"2003","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib13","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.immunol.16.1.137","article-title":"Regulation of immune responses by TGF-beta","volume":"16","author":"Letterio","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib14","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1002\/(SICI)1521-4141(199808)28:08<2487::AID-IMMU2487>3.0.CO;2-Y","article-title":"IL-12 is involved in the induction of experimental autoimmune Myasthenia Gravis, an antibody-mediated disease","volume":"28","author":"Moiola","year":"1998","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib15","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2003-41135","article-title":"Therapy in Myasthenia Gravis and Lambert-Eaton Myasthenic Syndrome","volume":"23","author":"Newsom-Davis","year":"2003","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib16","first-page":"S4","article-title":"Interleukin-6 in the pathogenesis of rheumatoid arthritis","volume":"65","author":"Park","year":"2007","journal-title":"Bull. NYU Hosp. Jt. Dis."},{"key":"10.1016\/j.jneuroim.2008.05.026_bib17","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2006.01.001","article-title":"TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells","volume":"24","author":"Veldhoen","year":"2006","journal-title":"Immunity"},{"key":"10.1016\/j.jneuroim.2008.05.026_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0165-5728(00)00411-2","article-title":"Interleukin 10 aggravates experimental autoimmune Myasthenia Gravis through inducing Th2 and B cell responses to AChR","volume":"113","author":"Zhang","year":"2001","journal-title":"J. Neuroimmunol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572808002142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:09:15Z","timestamp":1759046955000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572808002142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":18,"alternative-id":["S0165572808002142"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.05.026","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2008.05.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}